Resources

If you would like to learn more about meningococcal disease, there are many resources available. You can download and print useful tools, connect to relevant Web sites, browse a glossary of some commonly used terms, or check out frequently asked questions (FAQs).

Printable resources

Menveo® Parent Education Brochure 

Download the latest information on Menveo. Learn how you can help protect your child by preventing meningococcal disease.

Helpful questions to ask your healthcare provider 

Find out if your child is at risk. Take these questions with you on your next office visit.

 

Online links

American Academy of Family Physicians (AAFP)

Find resources, condition facts, and health tools from a credible source representing thousands of family physicians and medical students.

American Academy of Pediatrics (AAP)

Discover information on the health, developmental stages, and well-being of babies, children, teens, and adolescents.

Centers for Disease Control and Prevention (CDC) Parents' Guide to Childhood Immunizations

Learn about 14 childhood diseases and the vaccines that can help provide protection from them. The information is provided as a booklet that you can print out and keep handy. 

More CDC information about meningococcal meningitis

Connect with the US disease-fighting agency to get information about meningococcal meningitis. Explore symptoms, treatment, and where outbreaks and epidemics occur. Plus, find out about vaccinations.

Confederation of Meningitis Organisations (COMO)

Find out about this international organization, which is dedicated to helping meningitis organizations worldwide. Its focus is on battling meningococcal meningitis and bloodstream infection.

Immunization Action Coalition (IAC)

Access information about every recommended vaccine.

Meningitis Angels

Learn about this national organization, which educates the public about meningitis through parent and survivor stories and works with medical professionals, immunization coalitions, schools, and public health officials to encourage disease prevention through routine immunization. Meningitis Angels offers support to hundreds of families within the organization who have been victimized by meningitis.

Meningitis Foundation of America (MFA)

See how the MFA supports survivors of meningococcal meningitis and provides disease and vaccination information.

Meningitis Research Foundation

Learn about meningitis, meningitis research, and more from this UK research organization.

Moms on Meningitis (M.O.M.s)

Discover this group of parents who lost children to meningococcal meningitis or whose children had serious problems as a result of the disease.

National Foundation for Infectious Diseases (NFID) meningitis section

Access meningococcal meningitis information for parents and healthcare providers.

National Meningitis Association (NMA)

Visit here for disease and vaccine information for parents and healthcare providers.

World Health Organization (WHO)

Learn about meningococcal meningitis from this authority within the United Nations system. WHO also provides information on a variety of other health topics, offers publications and data/statistics, and operates healthcare programs around the world.

 

Indication

Menveo is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Menveo is approved for use in persons 11 to 55 years of age. Menveo does not prevent N. meningitidis serogroup B infections.

Important Safety Information

You should not receive Menveo if you have had a severe allergic reaction to any ingredient of the vaccine, or if you have had a severe allergic reaction to a vaccine containing similar components as Menveo.

Side effects to Menveo include pain at the injection site, headache, muscle pain, fatigue, nausea, and fainting. Sometimes fainting is accompanied by falling with injury. Other side effects may occur.

Following vaccination with a US-licensed meningococcal conjugate vaccine, an evaluation of postmarketing adverse events suggested a potential for increased risk of Guillain-Barré Syndrome (GBS). There is not enough information to evaluate if a risk of GBS exists following administration of Menveo.

Tell your doctor if you are pregnant or planning to get pregnant.

Vaccination with Menveo may not protect all individuals.

For more information about Menveo, talk to your health-care professional.

Menveo.com has been developed by Novartis Vaccines as part of the company’s commitment to individual and public health.

Menveo.com Exit Notice

You are now leaving the Menveo.com site and moving to an external website independently operated and not managed by Novartis Vaccines and Diagnostics Inc. Novartis assumes no responsibility for the site. If you do not wish to leave this site, click Cancel. Or, click OK to continue.

OKCancel